首页 News 正文

Johnson&Johnson CEO: Currently has no intention of producing weight loss drugs and focuses on expanding into fields such as neurology and oncology

我放心你带套猛
259 0 0

Johnson&Johnson CEO Joaquin Duato stated at the company's Investor Day event on December 5th that the company currently has no plans to produce weight loss pills due to the intense competition in the market.
Du Anqing stated that Johnson&Johnson is focusing on expanding widely in fields such as neurology and oncology. Du Anqing said, "If Johnson&Johnson has the opportunity to stand out in the weight loss drug market through assets that complement the company's business, it may reconsider."
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

我放心你带套猛 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    31